The HEMO share price tracks Hemogenyx Pharmaceuticals Plc, a clinical-stage biopharma developing treatments for blood and autoimmune disease. Here’s the current price, its 52-week range, and what actually drives it.
Quick Answer: HEMO Share Price
The HEMO share price sits at 667.00 pence, up 4.22% on the day, giving Hemogenyx Pharmaceuticals a market cap near £45.36 million. It trades on London’s AIM market under ticker HEMO, with roughly 6.80 million shares in issue. Because this is a snapshot rather than a live feed, check a real-time quote before trading — nothing here is financial advice.
1. HEMO Share Price Today
- Price: 667.00 pence, up about 4.22% on the day.
- Market: London Stock Exchange, AIM market, ticker HEMO.
- Market cap: Roughly £45.36 million, based on a small share count of about 6.80 million shares.
- Why the price looks high: So a small share count with a modest market cap can still show a price in the hundreds of pence, unlike most AIM stocks priced in single pence.
2. HEMO 52-Week Range and Volatility
- 52-week high: 1,790.00 pence, reached in September 2025.
- 52-week low: 133.50 pence, reached in August 2025.
- What that swing means: So the stock has moved more than tenfold across the past year, extreme even for a clinical-stage biotech.
- Why it swings so much: Because Hemogenyx has no product revenue yet, trial results and regulatory news each tend to trigger outsized single-day moves.
3. What Hemogenyx Pharmaceuticals Does
- Core business: Hemogenyx develops new treatments for blood and autoimmune diseases, working across several clinical-stage drug programmes.
- Why that matters: So a successful trial result or regulatory approval can transform the company’s value almost overnight.
- Stage: The company is pre-revenue and clinical-stage, so its share price leans entirely on trial progress rather than earnings.
- Funding: Like most clinical-stage biotechs, Hemogenyx relies on periodic share placings to fund its trials, which can dilute existing shareholders.
4. Key Factors That Move the HEMO Share Price
- Clinical trial results: Positive or negative trial data is the single biggest trigger for a sharp price move.
- Regulatory news: Updates from health regulators on trial approvals or holds can swing the stock heavily in either direction.
- Funding rounds: A fresh placing can pressure the price short term, even when the underlying trial news is positive.
- Biotech sector sentiment: Small-cap biotech stocks often move together during broader risk-appetite shifts across the sector.
Before You Trade HEMO Shares
- Check a live quote first. Clinical-stage biotech stocks can move fast around trial news.
- Read the RNS feed. Company announcements on the London Stock Exchange site carry the facts behind any price move.
- Understand the risk. Because pre-revenue biotechs carry high clinical and regulatory risk, this article is informational, not investment advice.
- Watch dilution. Track the share count over time, since future fundraising can affect existing shareholders.
For related reading, see our guides to UKOG Share Price: UK Oil & Gas Stock Today (2026) and THG Share Price: THG plc Stock Today (2026).
FAQ: HEMO Share Price
What is the HEMO share price today?
Around 667.00 pence, up roughly 4.22% on the day, with a market cap near £45.36 million.
What does Hemogenyx Pharmaceuticals do?
It develops clinical-stage treatments for blood and autoimmune diseases.
Why is the HEMO share price so volatile?
As a pre-revenue biotech, its price reacts sharply to clinical trial results, regulatory news, and funding updates.
Is HEMO on the FTSE?
No. HEMO trades on London’s AIM market, a segment built for smaller and growth-stage companies.
Where can I check the live HEMO share price?
The London Stock Exchange site and major finance data providers publish live AIM quotes through the trading day.
You may also like
ORCP Share Price: Oracle Power Stock Today (2026)
What Is a Trial Balance? How It Works and Why Your Books Need One (2026)
MET1 Share Price: Metals One Stock Today (2026)
EEE Share Price: Empire Metals Stock Today (2026)
HE1 Share Price: Helium One Global Stock Today (2026)
KEFI Share Price: Kefi Gold and Copper Stock Today (2026)
[…] might also find our HEMO Share Price: Hemogenyx Pharma Stock Today (2026) guide […]